PDCD1 and thyroid gland disorder: As an example, the higher frequency of autoantibody-related irAEs such as thyroid disorders in PD-1 treated patients could be a result of the modulation of humoral immunity by PD-1-inhibitors, or of its effects on self-tolerance.